Global Prostate Cancer Diagnostics Market to Reach $13.7 Billion by 2030
The global market for Prostate Cancer Diagnostics estimated at US$3.8 Billion in the year 2022, is projected to reach a revised size of US$13.7 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2022-2030. Preliminary, one of the segments analyzed in the report, is projected to record 16.3% CAGR and reach US$10 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Confirmatory segment is readjusted to a revised 20.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 22.6% CAGR
The Prostate Cancer Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 22.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 14.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.Select Competitors (Total 34 Featured) -
- 3D Signatures
- Abbott
- Beckman Coulter, Inc.
- Biomérieux Sa
- Diasorin S.P.A.
- F. Hoffman La Roche Ltd.
- Genomic Health
- Mdxhealth
- Myriad Genetic, Inc.
- Opko Health, Inc.
- Siemens Healthcare Gmbh
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Prostate Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Prostate Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Prostate Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Preliminary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Preliminary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Preliminary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Confirmatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Confirmatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Confirmatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Prostate Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 11: USA Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 12: USA Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 13: USA 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
CANADA
- Table 14: Canada Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 15: Canada Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 16: Canada 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
JAPAN
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 17: Japan Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 18: Japan Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 19: Japan 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
CHINA
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 20: China Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 21: China Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 22: China 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
EUROPE
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 23: Europe Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 24: Europe Historic Review for Prostate Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 25: Europe 16-Year Perspective for Prostate Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 26: Europe Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: Europe Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 28: Europe 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
FRANCE
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 29: France Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 30: France Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 31: France 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
GERMANY
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 32: Germany Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Germany Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 34: Germany 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
ITALY
- Table 35: Italy Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: Italy Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 37: Italy 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 38: UK Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: UK Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: UK 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
SPAIN
- Table 41: Spain Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Spain Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: Spain 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
RUSSIA
- Table 44: Russia Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Russia Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: Russia 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 47: Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: Rest of Europe Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: Rest of Europe 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 51: Asia-Pacific Historic Review for Prostate Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: Asia-Pacific 16-Year Perspective for Prostate Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Asia-Pacific Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: Asia-Pacific 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
AUSTRALIA
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- Table 56: Australia Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Australia Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: Australia 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
INDIA
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- Table 59: India Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: India Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: India 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
SOUTH KOREA
- Table 62: South Korea Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: South Korea Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 64: South Korea 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
- Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: Rest of Asia-Pacific Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 67: Rest of Asia-Pacific 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
LATIN AMERICA
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- Table 68: Latin America Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 69: Latin America Historic Review for Prostate Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 70: Latin America 16-Year Perspective for Prostate Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
- Table 71: Latin America Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: Latin America Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 73: Latin America 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
ARGENTINA
- Table 74: Argentina Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Argentina Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 76: Argentina 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
BRAZIL
- Table 77: Brazil Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: Brazil Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 79: Brazil 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
MEXICO
- Table 80: Mexico Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Mexico Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 82: Mexico 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
- Table 83: Rest of Latin America Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Latin America Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 85: Rest of Latin America 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
MIDDLE EAST
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- Table 86: Middle East Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 87: Middle East Historic Review for Prostate Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 88: Middle East 16-Year Perspective for Prostate Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
- Table 89: Middle East Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: Middle East Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 91: Middle East 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
IRAN
- Table 92: Iran Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Iran Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 94: Iran 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
ISRAEL
- Table 95: Israel Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Israel Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 97: Israel 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
SAUDI ARABIA
- Table 98: Saudi Arabia Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Saudi Arabia Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 100: Saudi Arabia 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
- Table 101: UAE Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 102: UAE Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 103: UAE 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
- Table 104: Rest of Middle East Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 105: Rest of Middle East Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 106: Rest of Middle East 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
AFRICA
- Prostate Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- Table 107: Africa Recent Past, Current & Future Analysis for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 108: Africa Historic Review for Prostate Cancer Diagnostics by Test Type - Preliminary and Confirmatory Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 109: Africa 16-Year Perspective for Prostate Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Preliminary and Confirmatory for the Years 2014, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Signatures
- Abbott
- Beckman Coulter, Inc.
- Biomérieux Sa
- Diasorin S.P.A.
- F. Hoffman La Roche Ltd.
- Genomic Health
- Mdxhealth
- Myriad Genetic, Inc.
- Opko Health, Inc.
- Siemens Healthcare Gmbh
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 3.8 Billion |
Forecasted Market Value ( USD | $ 13.7 Billion |
Compound Annual Growth Rate | 17.4% |
Regions Covered | Global |